Arrestin Pathways as Drug Targets - Progress in Molecular Biology and Translational Science - page 480

75. Seta K, Nanamori M, Modrall JG, Neubig RR, Sadoshima J. AT1 receptor mutant
lacking heterotrimeric G protein coupling activates the Src-Ras-ERK pathway with-
out nuclear translocation of ERKs. J Biol Chem . 2002;277:9268 - 9277.
76. Zhai P, Yamamoto M, Galeotti J, et al. Cardiac-specific overexpression of AT1 recep-
tor mutant lacking G alpha q/G alpha i coupling causes hypertrophy and bradycardia in
transgenic mice. J Clin Invest . 2005;115:3045 - 3056.
77. Ahn S, Kim J, Hara MR, Ren XR, Lefkowitz RJ. beta-Arrestin-2 mediates anti-
apoptotic signaling through regulation of BAD phosphorylation. J Biol Chem .

2009;284:8855 - 8865.
78. Wang P, Gao H, Ni Y, et al. Beta-arrestin 2 functions as a G-protein-coupled receptor-
activated regulator of oncoprotein Mdm2. J Biol Chem . 2003;278:6363 - 6370.
79. Noma T, Lemaire A, Naga Prasad SV, et al. Beta-arrestin-mediated beta1-adrenergic
receptor transactivation of the EGFR confers cardioprotection. J Clin Invest .

2007;117:2445 - 2458.
80. Penela P, Elorza A, Sarnago S, Mayor Jr F. Beta-arrestin- and c-Src-dependent degra-
dation of G-protein-coupled receptor kinase 2. EMBO J . 2001;20:5129 - 5138.
81. Ahn S, Maudsley S, Luttrell LM, Lefkowitz RJ, Daaka Y. Src-mediated tyrosine phos-
phorylation of dynamin is required for beta2-adrenergic receptor internalization and
mitogen-activated protein kinase signaling. J Biol Chem . 1999;274:1185- 1188.
82. Ahn S, Kim J, Lucaveche CL, et al. Src-dependent tyrosine phosphorylation regulates
dynamin self-assembly and ligand-induced endocytosis of the epidermal growth factor
receptor. J Biol Chem . 2002;277:26642 - 26651.
83. Fessart D, Simaan M, Zimmerman B, et al. Src-dependent phosphorylation of beta2-
adaptin dissociates the beta-arrestin-AP-2 complex. J Cell Sci . 2007;120:1723 - 1732.
84. Zimmerman B, Simaan M, Lee M-H, Luttrell LM, Laporte SA. c-Src-mediated phos-
phorylation of AP-2 reveals a general mechanism for receptors internalizing through
the clathrin pathway. Cell Signal . 2009;21:103 - 110.
85. Barlic J, Andrews JD, Kelvin AA, et al. Regulation of tyrosine kinase activation and
granule release through beta-arrestin by CXCRI. Nat Immunol . 2000;1:227 - 233.
86. Imamura T, Huang J, Dalle S, et al. beta-Arrestin-mediated recruitment of the Src fam-
ily kinase Yes mediates endothelin-1-stimulated glucose transport. J Biol Chem .
2001;276:43663 - 43667.
87. Ge L, Ly Y, Hollenberg M, DeFea K. A beta-arrestin-dependent scaffold is associated
with prolonged MAPK activation in pseudopodia during protease-activated receptor-
2-induced chemotaxis. J Biol Chem . 2003;278:34418 - 34426.
88. Ge L, Shenoy SK, Lefkowitz RJ, DeFea K. Constitutive protease-activated receptor-2-
mediated migration of MDA MB-231 breast cancer cells requires both beta-arrestin-1
and 2. J Biol Chem . 2004;279:55419- 55424.
89. Zoudilova M, Kumar P, Ge L, Wang P, Bokoch GM, DeFea KA. Beta-
arrestin-dependent regulation of the cofilin pathway downstream of protease-activated
receptor-2. J Biol Chem . 2007;282:20634 - 20646.
90. Li TT, Alemayehu M, Aziziyeh AI, et al. Beta-arrestin/Ral signaling regulates
lysophosphatidic acid-mediated migration and invasion of human breast tumor cells.
Mol Cancer Res . 2009;7:1064 - 1077.
91. Rosan` L, Cianfrocca R, Masi S, et al. Beta-arrestin links endothelin A receptor to
beta-catenin signaling to induce ovarian cancer cell invasion and metastasis. Proc Natl
Acad Sci USA . 2009;106:2806- 2811.
92. Fong AM, Premont RT, Richardson RM, Yu YR, Lefkowitz RJ, Patel DD. Defective
lymphocyte chemotaxis in beta-arrestin2- and GRK6-deficient mice. Proc Natl Acad Sci
USA . 2002;99:7478 - 7483.
93. Barlic J, Khandaker MH, Mahon E, et al. beta-Arrestins regulate interleukin-8-induced
CXCR1 internalization. J Biol Chem . 1999;274:16287 - 16294.